Press releases
- Politan Comments on Masimo’s Latest Entrenchment Maneuvers
- Masimo Files Complaint Seeking Injunction Requiring Politan to Correct Material Misstatements
- Leading Proxy Advisory Firm ISS Recommends Masimo Shareholders Vote FOR Both of Politan’s Director Nominees
- Masimo Responds to Politan’s Continuing Misrepresentations
- Leading Proxy Advisory Firm Glass Lewis Recommends Masimo Shareholders Vote FOR Both of Politan’s Director Nominees
- Masimo Independent Director Michelle Brennan Encourages Shareholders to Support an Urgently Needed Cultural Reset in the Company’s Boardroom
- Masimo Exposes Politan’s Governance Hypocrisy
- Masimo Announces Preliminary Second Quarter 2024 Revenue and Select Financial Results
- Masimo Provides Facts, Exposes False Narratives in Response to Latest Politan Fictions
- Masimo Nominee Christopher Chavez Would Bring Fierce Independence, Exemplary Medtech CEO Experience to Masimo Board
More ▼
Key statistics
As of last trade Masimo Corp (3M4:BRN) traded at 126.83, 0.00% below its 52-week high of 126.83, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 126.83 |
---|---|
High | 126.83 |
Low | 126.83 |
Bid | 126.07 |
Offer | 126.75 |
Previous close | 126.83 |
Average volume | -- |
---|---|
Shares outstanding | 53.18m |
Free float | 49.05m |
P/E (TTM) | 74.43 |
Market cap | 5.80bn USD |
EPS (TTM) | 1.46 USD |
Data delayed at least 15 minutes, as of Mar 26 2024.
More ▼